First-in-human trial assessing the pharmacokinetic-pharmacodynamic profile of a novel recombinant human chorionic gonadotropin in healthy women and men of reproductive age
https://ascpt.onlinelibrary.wiley.com/doi/full/10.1111/cts.13037
First published: 13 May 2021...
Therapy with human chorionic gonadotrophin alone induces spermatogenesis in men with isolated hypogonadotropic hypogonadism long-term follow-up (1992)
E. VICARI, et al
Summary
The effects of long-term (14-120 months) hCG-treatment of 17 male patients affected by isolated hypogonadotropic...